Cross-Talk between p53 and Wnt Signaling in Cancer

Qiyun Xiao1, Johannes Werner2, Nachiyappan Venkatachalam1

  • 1Department of Medicine II, Mannheim University Hospital, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.

Biomolecules
|March 25, 2022
PubMed

Insights

The p53 and Wnt pathways interact in cancer, influencing tumor growth and resistance to therapy. Understanding these interactions is key to developing new cancer treatments targeting this cross-talk.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Targeting cancer hallmarks is crucial for antineoplastic treatment.
  • Pathway cross-talk often leads to resistance against targeted therapies.
  • The p53 and Wnt pathways are vital in tumor onset and progression.

Purpose of the Study:

  • To provide a comprehensive overview of molecular interactions between the p53 and Wnt pathways in cancer.
  • To describe the mutational landscape of genes in p53 and Wnt signaling.
  • To discuss the functional consequences and therapeutic targeting of p53-Wnt cross-talk.

Main Methods:

  • Literature review of molecular interactions.
  • Analysis of genetic alterations in p53 and Wnt pathways.
  • Summary of functional consequences and therapeutic strategies.

Main Results:

  • Detailed description of molecular interactions, including feedback loops and reciprocal transactivation.
  • Characterization of mutual exclusive and co-occurring genetic alterations.
  • Identification of functional consequences like invasiveness, metastasis, and drug resistance.

Conclusions:

  • The cross-talk between p53 and Wnt pathways significantly impacts cancer phenotypes.
  • Targeting the p53-Wnt interaction presents potential therapeutic strategies for cancer treatment.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K